HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of HealthEquity (NASDAQ:HQY - Free Report) from a hold rating to a buy rating in a report issued on Friday.

Several other research analysts also recently weighed in on HQY. Barrington Research boosted their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price target for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Royal Bank of Canada lifted their target price on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday. Finally, KeyCorp lowered their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $118.09.

HealthEquity Trading Down 1.0%

Shares of HQY traded down $1.15 on Friday, hitting $111.55. 1,893,274 shares of the stock traded hands, compared to its average volume of 830,024. HealthEquity has a 1 year low of $65.01 and a 1 year high of $116.65. The stock's 50 day moving average is $91.48 and its two-hundred day moving average is $97.77. The firm has a market capitalization of $9.65 billion, a P/E ratio of 102.34, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the firm posted $0.80 EPS. As a group, sell-side analysts predict that HealthEquity will post 2.32 earnings per share for the current year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Institutional Trading of HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of HQY. Inspire Investing LLC raised its stake in HealthEquity by 8.6% during the first quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock worth $665,000 after acquiring an additional 597 shares during the period. Hodges Capital Management Inc. bought a new position in shares of HealthEquity during the first quarter worth about $1,988,000. Strs Ohio acquired a new stake in shares of HealthEquity in the 1st quarter worth about $999,000. Mattson Financial Services LLC increased its position in HealthEquity by 15.5% in the 1st quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock valued at $176,000 after acquiring an additional 267 shares during the period. Finally, Belpointe Asset Management LLC bought a new stake in HealthEquity during the 1st quarter valued at $756,000. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.